probenecid has been researched along with Peripheral Vascular Diseases in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Once-daily intravenous cefazolin with probenecid is used commonly to treat cellulitis." | 7.77 | Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid. ( Bader, MS; Hawboldt, J; Twells, L, 2011) |
| "Once-daily intravenous cefazolin with probenecid is used commonly to treat cellulitis." | 3.77 | Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid. ( Bader, MS; Hawboldt, J; Twells, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bader, MS | 1 |
| Twells, L | 1 |
| Hawboldt, J | 1 |
1 other study available for probenecid and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefazolin; Cellulitis; Chi-Square Distribution; Drug Th | 2011 |